Correlation Between Transcode Therapeutics and Revelation Biosciences
Can any of the company-specific risk be diversified away by investing in both Transcode Therapeutics and Revelation Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Transcode Therapeutics and Revelation Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Transcode Therapeutics and Revelation Biosciences, you can compare the effects of market volatilities on Transcode Therapeutics and Revelation Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Transcode Therapeutics with a short position of Revelation Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Transcode Therapeutics and Revelation Biosciences.
Diversification Opportunities for Transcode Therapeutics and Revelation Biosciences
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Transcode and Revelation is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Transcode Therapeutics and Revelation Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revelation Biosciences and Transcode Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Transcode Therapeutics are associated (or correlated) with Revelation Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revelation Biosciences has no effect on the direction of Transcode Therapeutics i.e., Transcode Therapeutics and Revelation Biosciences go up and down completely randomly.
Pair Corralation between Transcode Therapeutics and Revelation Biosciences
Given the investment horizon of 90 days Transcode Therapeutics is expected to generate 4.17 times more return on investment than Revelation Biosciences. However, Transcode Therapeutics is 4.17 times more volatile than Revelation Biosciences. It trades about 0.34 of its potential returns per unit of risk. Revelation Biosciences is currently generating about -0.01 per unit of risk. If you would invest 46.00 in Transcode Therapeutics on February 21, 2024 and sell it today you would earn a total of 73.00 from holding Transcode Therapeutics or generate 158.7% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Transcode Therapeutics vs. Revelation Biosciences
Performance |
Timeline |
Transcode Therapeutics |
Revelation Biosciences |
Transcode Therapeutics and Revelation Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Transcode Therapeutics and Revelation Biosciences
The main advantage of trading using opposite Transcode Therapeutics and Revelation Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Transcode Therapeutics position performs unexpectedly, Revelation Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revelation Biosciences will offset losses from the drop in Revelation Biosciences' long position.Transcode Therapeutics vs. Landos Biopharma | Transcode Therapeutics vs. Neximmune | Transcode Therapeutics vs. Xenetic Biosciences | Transcode Therapeutics vs. Reviva Pharmaceuticals Holdings |
Revelation Biosciences vs. Virax Biolabs Group | Revelation Biosciences vs. Kiora Pharmaceuticals | Revelation Biosciences vs. ZyVersa Therapeutics | Revelation Biosciences vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |